Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02466867 · ClinicalTrials.gov registry record · Phase 4
An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis
A Phase 4 study, sponsored by Merz North America.
- Completed
- Registry status
- Phase 4
- Development phase
- 27
- Enrollment target
NCT02466867 is a Phase 4 study that has completed, run by Merz North America. The registered enrollment target is 27 participants.
The verdict
NCT02466867, a Phase 4 study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 27 participants
- Enrollment target
Study Summary
This is an open label, multi-center, multi-application pharmacokinetic study in pediatric subjects with tinea corporis.
Interventions
- DRUG Naftin® Cream, 2% (younger pediatric cohort)
- DRUG Naftin® Cream, 2% (older pediatric cohort)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02466867
The ClinicalTrials.gov registry entry for NCT02466867 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naftin® Cream, 2% (younger pediatric cohort) is the first listed.
NCT02466867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02466867 about?
NCT02466867 is a clinical study titled "An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis". This is an open label, multi-center, multi-application pharmacokinetic study in pediatric subjects with tinea corporis.
What is the current status of trial NCT02466867?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 27 participants. The study started on 2014-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02466867?
The interventions under investigation include: Naftin® Cream, 2% (younger pediatric cohort) (DRUG), Naftin® Cream, 2% (older pediatric cohort) (DRUG).
Who is sponsoring clinical trial NCT02466867?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.